OTC Healthcare in Greece to 2011

Datamonitor, August 2008, Pages: 183

This databook is a detailed information resource covering all the key data points on OTC Healthcare in Greece. It includes comprehensive value volume segmentation and market share data. The databook supplies actual data to 2006 and full forecasts to 2011.

Scope

- Contains information on:Analgesics,Cough & cold,Indigestion,Medicated skin products,Traditional medicines,Vitamins & Other OTC healthcare products

- Provides market value, volume, expenditure and consumption data by market, segment and subsegment

- Includes company and brand share data by categories

Highlights of this title

The market for OTC Healthcare in Greece increased between 2001-2006, growing at an average annual rate of 5.9%.

The leading company in the market in 2006 was Pfizer Inc. The second-largest player was Korres Natural Products S.A. with Bayer AG in third place.

Key reasons to purchase this title

- Discover the major quantitative trends affecting the OTC Healthcare markets

- Understand consumers consumption and expenditure patterns

- Understand the future direction of the market with reliable historical data and full five year forecasting

Chapter 1 EXECUTIVE SUMMARY 2
Summary Market Level - OTC Healthcare 2
Summary category level - Analgesics 3
Summary category level - Cough and Cold Preparations 4
Summary category level - Traditional Medicines 5
Summary category level - First Aid Kits 6
Summary category level - Indigestion Preparations 7
Summary category level - Vitamins and Minerals 8
Summary category level - Plasters & Bandages 9
Summary category level - Medicated Skin Products 10
Summary category level - Other OTC Healthcare Products 11
Summary category level - Topical OTC Medicines 12
Chapter 2 INTRODUCTION 13
What is this report about? 13
How to use this report 13
Market Definition 14
Chapter 3 MARKET OVERVIEW 31
Value Analysis, 2001-2006 31
Value Analysis, 2006-2011 33
Value Analysis, US$ 2001-2006 36
Value Analysis, US$ 2006-2011 37
Company and Brand Share Analysis 39
Expenditure & consumption per capita 46
Chapter 4 LEADING COMPANY PROFILES 50
Pfizer Inc 50
Chapter 5 CATEGORY ANALYSIS - ANALGESICS 52
Value Analysis, 2001-2006 52
Value Analysis, 2006-2011 53
Value Analysis, US$ 2001-2006 55
Value Analysis, US$ 2006-2011 56
Company and Brand Share Analysis 58
Expenditure & consumption per capita 61
Chapter 6 CATEGORY ANALYSIS - COUGH AND COLD PREPARATIONS 63
Value Analysis, 2001-2006 63
Value Analysis, 2006-2011 64
Value Analysis, US$ 2001-2006 66
Value Analysis, US$ 2006-2011 67
Company and Brand Share Analysis 69
Expenditure & consumption per capita 72
Chapter 7 CATEGORY ANALYSIS - TRADITIONAL MEDICINES 75
Value Analysis, 2001-2006 75
Value Analysis, 2006-2011 76
Value Analysis, US$ 2001-2006 78
Value Analysis, US$ 2006-2011 78
Company and Brand Share Analysis 79
Expenditure & consumption per capita 81
Chapter 8 CATEGORY ANALYSIS - FIRST AID KITS 83
Value Analysis, 2001-2006 83
Value Analysis, 2006-2011 84
Value Analysis, US$ 2001-2006 86
Value Analysis, US$ 2006-2011 86
Company and Brand Share Analysis 87
Expenditure & consumption per capita 90
Chapter 9 CATEGORY ANALYSIS - INDIGESTION PREPARATIONS 92
Value Analysis, 2001-2006 92
Value Analysis, 2006-2011 93
Value Analysis, US$ 2001-2006 95
Value Analysis, US$ 2006-2011 95
Company and Brand Share Analysis 97
Expenditure & consumption per capita 100
Chapter 10 CATEGORY ANALYSIS - VITAMINS AND MINERALS 102
Value Analysis, 2001-2006 102
Value Analysis, 2006-2011 103
Value Analysis, US$ 2001-2006 105
Value Analysis, US$ 2006-2011 105
Company and Brand Share Analysis 107
Expenditure & consumption per capita 111
Chapter 11 CATEGORY ANALYSIS - PLASTERS & BANDAGES 113
Value Analysis, 2001-2006 113
Value Analysis, 2006-2011 114
Value Analysis, US$ 2001-2006 116
Value Analysis, US$ 2006-2011 117
Company and Brand Share Analysis 119
Expenditure & consumption per capita 122
Chapter 12 CATEGORY ANALYSIS - MEDICATED SKIN PRODUCTS 125
Value Analysis, 2001-2006 125
Value Analysis, 2006-2011 126
Value Analysis, US$ 2001-2006 128
Value Analysis, US$ 2006-2011 129
Company and Brand Share Analysis 131
Expenditure & consumption per capita 134
Chapter 13 CATEGORY ANALYSIS - OTHER OTC HEALTHCARE PRODUCTS 137
Value Analysis, 2001-2006 137
Value Analysis, 2006-2011 138
Value Analysis, US$ 2001-2006 140
Value Analysis, US$ 2006-2011 141
Company and Brand Share Analysis 143
Expenditure & consumption per capita 146
Chapter 14 CATEGORY ANALYSIS - TOPICAL OTC MEDICINES 149
Value Analysis, 2001-2006 149
Value Analysis, 2006-2011 150
Value Analysis, US$ 2001-2006 152
Value Analysis, US$ 2006-2011 153
Company and Brand Share Analysis 155
Expenditure & consumption per capita 157
Chapter 15 COUNTRY COMPARISON 160
Value 160
Market Share 165
Chapter 16 NEW PRODUCT DEVELOPMENT 166
Product launches over time 166
Recent product launches 167
Chapter 17 GREECE SOCIOECONOMIC PROFILE 168
Country Overview 168
Key Facts 169
Political Overview 170
Greece Economic Overview 171
Chapter 18 GREECE MACROECONOMIC PROFILE 172
Macroeconomic Indicators 172
Chapter 19 RESEARCH METHODOLOGY 179
Methodology overview 179
Secondary research 180
Market modelling 181
Primary research 182
Data finalisation 182
Ongoing research 183
Chapter 20 APPENDIX 184
Future readings 184
How to contact experts in your industry 184

LIST OF FIGURES
Figure 1: Greece OTC Healthcare value & value forecast, 2001-2011 (EUR m, nominal prices) 35
Figure 2: Greece OTC Healthcare category growth comparison, by value, 2001-2011 38
Figure 3: Greece OTC Healthcare company share, by value, 2005-2006 (%) 43
Figure 4: Greece Analgesics value & value forecast, 2001-2011 (EUR m, nominal prices) 54
Figure 5: Greece Analgesics category growth comparison, by value, 2001-2011 57
Figure 6: Greece Analgesics company share, by value, 2005-2006 (%) 59
Figure 7: Greece Cough and Cold Preparations value & value forecast, 2001-2011 (EUR m, nominal prices) 65
Figure 8: Greece Cough and Cold Preparations category growth comparison, by value, 2001-2011 68
Figure 9: Greece Cough and Cold Preparations company share, by value, 2005-2006 (%) 70
Figure 10: Greece Traditional Medicines value & value forecast, 2001-2011 (EUR m, nominal prices) 77
Figure 11: Greece First Aid Kits value & value forecast, 2001-2011 (EUR m, nominal prices) 85
Figure 12: Greece First Aid Kits company share, by value, 2005-2006 (%) 88
Figure 13: Greece Indigestion Preparations value & value forecast, 2001-2011 (EUR m, nominal prices) 94
Figure 14: Greece Indigestion Preparations category growth comparison, by value, 2001-2011 96
Figure 15: Greece Indigestion Preparations company share, by value, 2005-2006 (%) 98
Figure 16: Greece Vitamins and Minerals value & value forecast, 2001-2011 (EUR m, nominal prices) 104
Figure 17: Greece Vitamins and Minerals category growth comparison, by value, 2001-2011 106
Figure 18: Greece Vitamins and Minerals company share, by value, 2005-2006 (%) 108
Figure 19: Greece Plasters & Bandages value & value forecast, 2001-2011 (EUR m, nominal prices) 115
Figure 20: Greece Plasters & Bandages category growth comparison, by value, 2001-2011 118
Figure 21: Greece Plasters & Bandages company share, by value, 2005-2006 (%) 120
Figure 22: Greece Medicated Skin Products value & value forecast, 2001-2011 (EUR m, nominal prices) 127
Figure 23: Greece Medicated Skin Products category growth comparison, by value, 2001-2011 130
Figure 24: Greece Medicated Skin Products company share, by value, 2005-2006 (%) 132
Figure 25: Greece Other OTC Healthcare Products value & value forecast, 2001-2011 (EUR m, nominal prices) 139
Figure 26: Greece Other OTC Healthcare Products category growth comparison, by value, 2001-2011 142
Figure 27: Greece Other OTC Healthcare Products company share, by value, 2005-2006 (%) 144
Figure 28: Greece Topical OTC Medicines value & value forecast, 2001-2011 (EUR m, nominal prices) 151
Figure 29: Greece Topical OTC Medicines category growth comparison, by value, 2001-2011 154
Figure 30: Global OTC Healthcare market split (value terms, 2006) - Top 5 countries 161
Figure 31: Global OTC Healthcare market value, 2001 - 2006 (Top 5 countries) 164
Figure 32: Map of Greece 169
Figure 33: Annual data review process 180

LIST OF TABLES
Table 1: OTC Healthcare category definitions 15
Table 2: Greece OTC Healthcare value, 2001-2006 (EUR m, nominal prices) 32
Table 3: Greece OTC Healthcare value forecast, 2006-2011 (EUR m, nominal prices) 34
Table 4: Greece OTC Healthcare value, 2001-2006 (US$ m nominal prices) 36
Table 5: Greece OTC Healthcare value forecast, 2006-2011 (US$ m nominal prices) 37
Table 6: Greece OTC Healthcare brand share, by value, 2005-2006 (%) 39
Table 7: Greece OTC Healthcare value, by brand 2005-2006 (EUR m nominal prices) 41
Table 8: Greece OTC Healthcare company share by value, 2005-2006 (%) 44
Table 9: Greece OTC Healthcare value, by company, 2005-2006 (EUR m nominal prices) 45
Table 10: Greece OTC Healthcare expenditure per capita, 2001-2006 (EUR, nominal prices) 46
Table 11: Greece OTC Healthcare forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 47
Table 12: Greece OTC Healthcare expenditure per capita, 2001-2006 (US$ nominal prices) 48
Table 13: Greece OTC Healthcare forecast expenditure per capita, 2006-2011 (US$ nominal prices) 49
Table 14: Pfizer Inc Key Facts 50
Table 15: Greece Analgesics value, 2001-2006 (EUR m, nominal prices) 52
Table 16: Greece Analgesics value forecast, 2006-2011 (EUR m, nominal prices) 53
Table 17: Greece Analgesics value, 2001-2006 (US$ m nominal prices) 55
Table 18: Greece Analgesics value forecast, 2006-2011 (US$ m nominal prices) 56
Table 19: Greece Analgesics brand share, by value, 2005-2006 (%) 58
Table 20: Greece Analgesics value, by brand 2005-2006 (EUR m nominal prices) 58
Table 21: Greece Analgesics company share by value, 2005-2006 (%) 60
Table 22: Greece Analgesics value, by company, 2005-2006 (EUR m nominal prices) 60
Table 23: Greece Analgesics expenditure per capita, 2001-2006 (EUR, nominal prices) 61
Table 24: Greece Analgesics forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 61
Table 25: Greece Analgesics expenditure per capita, 2001-2006 (US$ nominal prices) 62
Table 26: Greece Analgesics forecast expenditure per capita, 2006-2011 (US$ nominal prices) 62
Table 27: Greece Cough and Cold Preparations value, 2001-2006 (EUR m, nominal prices) 63
Table 28: Greece Cough and Cold Preparations value forecast, 2006-2011 (EUR m, nominal prices) 64
Table 29: Greece Cough and Cold Preparations value, 2001-2006 (US$ m nominal prices) 66
Table 30: Greece Cough and Cold Preparations value forecast, 2006-2011 (US$ m nominal prices) 67
Table 31: Greece Cough and Cold Preparations brand share, by value, 2005-2006 (%) 69
Table 32: Greece Cough and Cold Preparations value, by brand 2005-2006 (EUR m nominal prices) 69
Table 33: Greece Cough and Cold Preparations company share by value, 2005-2006 (%) 71
Table 34: Greece Cough and Cold Preparations value, by company, 2005-2006 (EUR m nominal prices) 71
Table 35: Greece Cough and Cold Preparations expenditure per capita, 2001-2006 (EUR, nominal prices) 72
Table 36: Greece Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 73
Table 37: Greece Cough and Cold Preparations expenditure per capita, 2001-2006 (US$ nominal prices) 74
Table 38: Greece Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices) 74
Table 39: Greece Traditional Medicines value, 2001-2006 (EUR m, nominal prices) 75
Table 40: Greece Traditional Medicines value forecast, 2006-2011 (EUR m, nominal prices) 76
Table 41: Greece Traditional Medicines value, 2001-2006 (US$ m nominal prices) 78
Table 42: Greece Traditional Medicines value forecast, 2006-2011 (US$ m nominal prices) 78
Table 43: Greece Traditional Medicines brand share, by value, 2005-2006 (%) 79
Table 44: Greece Traditional Medicines value, by brand 2005-2006 (EUR m nominal prices) 79
Table 45: Greece Traditional Medicines company share by value, 2005-2006 (%) 80
Table 46: Greece Traditional Medicines value, by company, 2005-2006 (EUR m nominal prices) 80
Table 47: Greece Traditional Medicines expenditure per capita, 2001-2006 (EUR, nominal prices) 81
Table 48: Greece Traditional Medicines forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 81
Table 49: Greece Traditional Medicines expenditure per capita, 2001-2006 (US$ nominal prices) 82
Table 50: Greece Traditional Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices) 82
Table 51: Greece First Aid Kits value, 2001-2006 (EUR m, nominal prices) 83
Table 52: Greece First Aid Kits value forecast, 2006-2011 (EUR m, nominal prices) 84
Table 53: Greece First Aid Kits value, 2001-2006 (US$ m nominal prices) 86
Table 54: Greece First Aid Kits value forecast, 2006-2011 (US$ m nominal prices) 86
Table 55: Greece First Aid Kits brand share, by value, 2005-2006 (%) 87
Table 56: Greece First Aid Kits value, by brand 2005-2006 (EUR m nominal prices) 87
Table 57: Greece First Aid Kits company share by value, 2005-2006 (%) 89
Table 58: Greece First Aid Kits value, by company, 2005-2006 (EUR m nominal prices) 89
Table 59: Greece First Aid Kits expenditure per capita, 2001-2006 (EUR, nominal prices) 90
Table 60: Greece First Aid Kits forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 90
Table 61: Greece First Aid Kits expenditure per capita, 2001-2006 (US$ nominal prices) 91
Table 62: Greece First Aid Kits forecast expenditure per capita, 2006-2011 (US$ nominal prices) 91
Table 63: Greece Indigestion Preparations value, 2001-2006 (EUR m, nominal prices) 92
Table 64: Greece Indigestion Preparations value forecast, 2006-2011 (EUR m, nominal prices) 93
Table 65: Greece Indigestion Preparations value, 2001-2006 (US$ m nominal prices) 95
Table 66: Greece Indigestion Preparations value forecast, 2006-2011 (US$ m nominal prices) 95
Table 67: Greece Indigestion Preparations brand share, by value, 2005-2006 (%) 97
Table 68: Greece Indigestion Preparations value, by brand 2005-2006 (EUR m nominal prices) 97
Table 69: Greece Indigestion Preparations company share by value, 2005-2006 (%) 99
Table 70: Greece Indigestion Preparations value, by company, 2005-2006 (EUR m nominal prices) 99
Table 71: Greece Indigestion Preparations expenditure per capita, 2001-2006 (EUR, nominal prices) 100
Table 72: Greece Indigestion Preparations forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 100
Table 73: Greece Indigestion Preparations expenditure per capita, 2001-2006 (US$ nominal prices) 101
Table 74: Greece Indigestion Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices) 101
Table 75: Greece Vitamins and Minerals value, 2001-2006 (EUR m, nominal prices) 102
Table 76: Greece Vitamins and Minerals value forecast, 2006-2011 (EUR m, nominal prices) 103
Table 77: Greece Vitamins and Minerals value, 2001-2006 (US$ m nominal prices) 105
Table 78: Greece Vitamins and Minerals value forecast, 2006-2011 (US$ m nominal prices) 105
Table 79: Greece Vitamins and Minerals brand share, by value, 2005-2006 (%) 107
Table 80: Greece Vitamins and Minerals value, by brand 2005-2006 (EUR m nominal prices) 107
Table 81: Greece Vitamins and Minerals company share by value, 2005-2006 (%) 109
Table 82: Greece Vitamins and Minerals value, by company, 2005-2006 (EUR m nominal prices) 110
Table 83: Greece Vitamins and Minerals expenditure per capita, 2001-2006 (EUR, nominal prices) 111
Table 84: Greece Vitamins and Minerals forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 111
Table 85: Greece Vitamins and Minerals expenditure per capita, 2001-2006 (US$ nominal prices) 112
Table 86: Greece Vitamins and Minerals forecast expenditure per capita, 2006-2011 (US$ nominal prices) 112
Table 87: Greece Plasters & Bandages value, 2001-2006 (EUR m, nominal prices) 113
Table 88: Greece Plasters & Bandages value forecast, 2006-2011 (EUR m, nominal prices) 114
Table 89: Greece Plasters & Bandages value, 2001-2006 (US$ m nominal prices) 116
Table 90: Greece Plasters & Bandages value forecast, 2006-2011 (US$ m nominal prices) 117
Table 91: Greece Plasters & Bandages brand share, by value, 2005-2006 (%) 119
Table 92: Greece Plasters & Bandages value, by brand 2005-2006 (EUR m nominal prices) 119
Table 93: Greece Plasters & Bandages company share by value, 2005-2006 (%) 121
Table 94: Greece Plasters & Bandages value, by company, 2005-2006 (EUR m nominal prices) 121
Table 95: Greece Plasters & Bandages expenditure per capita, 2001-2006 (EUR, nominal prices) 122
Table 96: Greece Plasters & Bandages forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 123
Table 97: Greece Plasters & Bandages expenditure per capita, 2001-2006 (US$ nominal prices) 124
Table 98: Greece Plasters & Bandages forecast expenditure per capita, 2006-2011 (US$ nominal prices) 124
Table 99: Greece Medicated Skin Products value, 2001-2006 (EUR m, nominal prices) 125
Table 100: Greece Medicated Skin Products value forecast, 2006-2011 (EUR m, nominal prices) 126
Table 101: Greece Medicated Skin Products value, 2001-2006 (US$ m nominal prices) 128
Table 102: Greece Medicated Skin Products value forecast, 2006-2011 (US$ m nominal prices) 129
Table 103: Greece Medicated Skin Products brand share, by value, 2005-2006 (%) 131
Table 104: Greece Medicated Skin Products value, by brand 2005-2006 (EUR m nominal prices) 131
Table 105: Greece Medicated Skin Products company share by value, 2005-2006 (%) 133
Table 106: Greece Medicated Skin Products value, by company, 2005-2006 (EUR m nominal prices) 133
Table 107: Greece Medicated Skin Products expenditure per capita, 2001-2006 (EUR, nominal prices) 134
Table 108: Greece Medicated Skin Products forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 135
Table 109: Greece Medicated Skin Products expenditure per capita, 2001-2006 (US$ nominal prices) 136
Table 110: Greece Medicated Skin Products forecast expenditure per capita, 2006-2011 (US$ nominal prices) 136
Table 111: Greece Other OTC Healthcare Products value, 2001-2006 (EUR m, nominal prices) 137
Table 112: Greece Other OTC Healthcare Products value forecast, 2006-2011 (EUR m, nominal prices) 138
Table 113: Greece Other OTC Healthcare Products value, 2001-2006 (US$ m nominal prices) 140
Table 114: Greece Other OTC Healthcare Products value forecast, 2006-2011 (US$ m nominal prices) 141
Table 115: Greece Other OTC Healthcare Products brand share, by value, 2005-2006 (%) 143
Table 116: Greece Other OTC Healthcare Products value, by brand 2005-2006 (EUR m nominal prices) 143
Table 117: Greece Other OTC Healthcare Products company share by value, 2005-2006 (%) 145
Table 118: Greece Other OTC Healthcare Products value, by company, 2005-2006 (EUR m nominal prices) 145
Table 119: Greece Other OTC Healthcare Products expenditure per capita, 2001-2006 (EUR, nominal prices) 146
Table 120: Greece Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 147
Table 121: Greece Other OTC Healthcare Products expenditure per capita, 2001-2006 (US$ nominal prices) 148
Table 122: Greece Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (US$ nominal prices) 148
Table 123: Greece Topical OTC Medicines value, 2001-2006 (EUR m, nominal prices) 149
Table 124: Greece Topical OTC Medicines value forecast, 2006-2011 (EUR m, nominal prices) 150
Table 125: Greece Topical OTC Medicines value, 2001-2006 (US$ m nominal prices) 152
Table 126: Greece Topical OTC Medicines value forecast, 2006-2011 (US$ m nominal prices) 153
Table 127: Greece Topical OTC Medicines brand share, by value, 2005-2006 (%) 155
Table 128: Greece Topical OTC Medicines value, by brand 2005-2006 (EUR m nominal prices) 155
Table 129: Greece Topical OTC Medicines company share by value, 2005-2006 (%) 156
Table 130: Greece Topical OTC Medicines value, by company, 2005-2006 (EUR m nominal prices) 156
Table 131: Greece Topical OTC Medicines expenditure per capita, 2001-2006 (EUR, nominal prices) 157
Table 132: Greece Topical OTC Medicines forecast expenditure per capita, 2006-2011 (EUR, nominal prices) 158
Table 133: Greece Topical OTC Medicines expenditure per capita, 2001-2006 (US$ nominal prices) 159
Table 134: Greece Topical OTC Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices) 159
Table 135: Global OTC Healthcare market value, 2006 160
Table 136: Global OTC Healthcare market split (value terms (US$ m), 2006) - Top 5 countries 163
Table 137: Leading players - Top 5 countries 165
Table 138: Greece OTC Healthcare new product launches (reports) and SKUs, by company 2006 166
Table 139: Greece OTC Healthcare new product launches (reports), by Ingredients 2006 166
Table 140: Greece OTC Healthcare new product launches (reports), by Package tags or Claims (Top 10 claims), 2006 167
Table 141: Greece OTC Healthcare new product launches (reports) - Recent 5 launches 167
Table 142: Greece Key Facts 169
Table 143: Greece population, by age group, 2000-2005 (millions) 172
Table 144: Greece population forecast, by age group, 2005-2010 (millions) 173
Table 145: Greece population, by gender, 2000-2005 (millions) 173
Table 146: Greece population forecast, by gender, 2005-2010 (millions) 174
Table 147: Greece real GDP, 2000-2005 (EUR bn, 2005 prices) 174
Table 148: Greece real GDP forecast, 2005-2010 (EUR bn, 2005 prices) 175
Table 149: Greece nominal GDP, 2000-2005 (EUR bn, nominal prices) 175
Table 150: Greece real GDP, 2000-2005 (US$ bn, 2005 prices) 176
Table 151: Greece real GDP forecast, 2005-2010 (US$ bn, 2005 prices) 176
Table 152: Greece consumer price index, 2000-2005 (2000=100) 177
Table 153: Greece consumer price index, 2005-2010 (2000=100) 177
Table 154: Greece exchange rate, 2000-2005 178

Customers who bought this item also bought

• Pediatric Drugs and Vaccines - Global Business Strategic Report
• Antibiotics - Global Strategic Business Report
• CNS Therapeutics - Global Strategic Business Report
• Global Biopharmaceutical Market Report & Forecast (2012-2017)
• World Vaccines Market: Vaccine Segments Analysis, Vaccine Cases and Future Forecast
• IV Fluid Transfer Devices Products, Players, Markets and Opportunities
• RNA Interference (RNAi) - Global Strategic Business Report
• Truck Bedliners - Global Strategic Business Report
• Nuclear Medicine - Global Strategic Business Report
• Pain Management Devices - Global Strategic Business Report